Ad
Sunday, 20 August 2017
Samsung Bioepis teams up with Takeda to develop original biotech drugs
SEOUL (Reuters) - Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment